Sedative Effects in Obstructive Sleep Apnea

NCT01733043 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Failure to secure funding

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: Dexmedetomidine
DRUG: Placebo

Sponsor

Duke University